Mubarak Al‐Μansour

ORCID: 0000-0002-2919-4924
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Lung Cancer Treatments and Mutations
  • CNS Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Renal cell carcinoma treatment
  • Renal and related cancers
  • Cancer Genomics and Diagnostics
  • CAR-T cell therapy research
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Bladder and Urothelial Cancer Treatments
  • Cutaneous lymphoproliferative disorders research
  • Glioma Diagnosis and Treatment
  • Innovations in Medical Education
  • Urinary and Genital Oncology Studies
  • Cancer Immunotherapy and Biomarkers
  • COVID-19 and healthcare impacts
  • HER2/EGFR in Cancer Research
  • Multiple and Secondary Primary Cancers
  • Radiomics and Machine Learning in Medical Imaging
  • Esophageal Cancer Research and Treatment
  • Education and Critical Thinking Development
  • T-cell and Retrovirus Studies

National Guard Health Affairs
2016-2024

King Abdulaziz Medical City
2015-2024

King Saud bin Abdulaziz University for Health Sciences
2016-2024

King Abdullah International Medical Research Center
2021-2024

Imam Abdulrahman Bin Faisal University
2020

King Fahd Medical City
2018

King Fahad Specialist Hospital
2018

King Faisal Specialist Hospital & Research Centre
2014-2018

Riyadh Armed Forces Hospital
2014-2016

King Khaled Hospital
2014

PURPOSE Prior observations suggest a higher risk of transformation nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL) to aggressive lymphoma, most commonly diffuse large B-cell (DLBCL), than in classical lymphoma. We evaluated the frequency all patients diagnosed with NLPHL at British Columbia Cancer Agency long-term follow-up. PATIENTS AND METHODS The Lymphoid Database was searched identify between 1965 and 2006. After pathologic review, 95 were confirmed. Results Patients had...

10.1200/jco.2009.24.9516 article EN Journal of Clinical Oncology 2010-01-05

Introduction Poor knowledge retention is one reason for medical student attrition in learning and has been a huge concern education. Three-dimensional virtual reality (3D-VR)-based teaching education promoted to improve outcomes. This study aimed determine the effectiveness of 3D-VR human anatomy courses as compared traditional methods among students. Methods A convergent mixed design was utilized evaluate outcomes terms short- long-term scores students using those models describe students'...

10.7759/cureus.7085 article EN Cureus 2020-02-24

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's (NHL), representing 30% all cases. Within first 2-3 years following immunochemotherapy, 30-40% patients will experience a relapse or refractory disease, thereby exhibiting poor prognosis. High-dose immunotherapy followed by autologous stem cell transplantation standard care for relapsed/refractory (RR) with DLBCL. However, >60% are ineligible transplant, presenting therapeutic challenge. Chimeric antigen...

10.3892/mco.2020.2103 article EN Molecular and Clinical Oncology 2020-07-29

Background. A culture of quality is believed to drive institutes toward excellence through feedback. Multiple surveys at educational institute help get a deeper insight into institutional performance and curricular execution. Since problem-based learning (PBL) an important component the hybrid curriculum, thus stakeholders’ opinion on PBL satisfaction worth discussing. This study intended determine trends in students’ with over years report importance changes that can be incorporated based...

10.1155/2023/9955409 article EN cc-by Education Research International 2023-02-13

<b><i>Background:</i></b> Hodgkin lymphoma (HL) exhibits considerable clinicopathological variations in different parts of the world. This study was prompted by limited availability HL data developing countries (particularly long-term outcomes). <b><i>Methods:</i></b> We performed a retrospective review eligible adult patients treated at 3 tertiary centers Saudi Arabia between January 1997 and December 2012....

10.1159/000460819 article EN Oncology Research and Treatment 2017-01-01

In this report, updated guidelines for the evaluation, medical, and surgical management of transitional cell carcinoma urinary bladder are resented. They categorized according stage disease using TNM staging system 7th edition. The recommendations presented with supporting level evidence.

10.4103/0974-7796.140941 article EN cc-by-nc-sa Urology Annals 2014-01-01

Graves' disease (GD) and Hashimoto's thyroiditis (HT) are the most common types of autoimmune thyroid diseases (AITD), both characterized by infiltration lymphocytes into gland. Moreover, like HT have a higher risk developing lymphoma. This study is aimed at assessing prevalence association lymphoma in patients with AITD.This cross-sectional was conducted King Abdulaziz Medical City, Jeddah, Saudi Arabia. Data were gathered from medical records aged 18 years or older who developed AITD. A...

10.1155/2022/4354595 article EN Disease Markers 2022-06-03

Background: Metastatic renal cell carcinoma (mRCC) represents a challenging condition characterised by poor prognosis and limited response to chemoradiotherapy. In this retrospective study, we compared the survival outcomes of first-line ICI regimens versus single-agent TKIs in patients with mRCC from two centres Saudi Arabia. Methods: This study included 84 diagnosed clear between January 2016 December 2023. Patients were grouped based on treatment regimens. Progression-free (PFS) overall...

10.3390/cancers16183234 article EN Cancers 2024-09-23

B-HOLISTIC was a real-world, retrospective study of treatment patterns and clinical outcomes in Hodgkin lymphoma (HL) regions outside Europe North America. This subgroup analysis reports findings from Saudi Arabia, Türkiye, South Africa.

10.4274/tjh.galenos.2024.2024.0181 article EN cc-by-nc-nd Turkish Journal of Hematology 2024-10-24

Administration of effective anticancer treatments should continue during pandemics. However, the outcomes curative and palliative coronavirus disease (COVID‑19) pandemic remain unclear. The present retrospective observational study aimed to determine 30‑day mortality morbidity COVID‑19 pandemic. Between March 1 June 30, 2020, all adults (n=2,504) with solid hematological malignancies irrespective cancer stage type at five large comprehensive centers in Saudi Arabia were included. was 5.1%...

10.3892/mco.2021.2244 article EN Molecular and Clinical Oncology 2021-02-26

Hepatitis B virus (HBV) is one of the most prevalent and serious infections worldwide. HBV reactivation a complication for lymphoma patients who are being treated with rituximab-containing regimen. Since impact has not been fully evaluated on prognosis diffuse large cell (DLBCL), this study examined effect hepatitis infection progression-free survival (PFS) overall (OS) in DLBCL received chemotherapy.This retrospective cohort was conducted at Princess Noorah Oncology Center, Jeddah by...

10.1186/s13027-018-0190-9 article EN cc-by Infectious Agents and Cancer 2018-06-07
Coming Soon ...